DEF 14C: Advanced Biomed Plans Reverse Stock Split for Nasdaq Listing

Advanced Biomed Inc. announces a planned reverse stock split, ranging from 1:2 to 1:100, to maintain its listing on The Nasdaq Capital Market.

Summary

• The Board of Directors and Majority Stockholders of Advanced Biomed Inc. have approved a reverse stock split of the company's common stock.
• The reverse stock split ratio will be within a range of one-for-two (1:2) to one-for-one hundred (1:100), to be determined by the Board of Directors.
• The primary purpose of the Reverse Stock Split is to raise the per share trading price of the common stock to maintain the company's listing on The Nasdaq Capital Market.
• The action was approved by written consent on January 12, 2026, by stockholders owning approximately 79.92% of the voting power.
• The corporate action is anticipated to become effective on February 13, 2026, or a later date specified in the Certificate of Amendment filing.
• The Reverse Stock Split will not change the number of authorized shares or the par value ($0.001) of the common stock.
• Fractional shares resulting from the split will be rounded up to the nearest whole share.

Sentiment

Score: 3

Explanation: The sentiment is generally negative. While the stated goal of maintaining Nasdaq listing is positive, a reverse stock split is typically a defensive measure taken due to a low stock price, often signaling underlying business challenges. The filing explicitly mentions the risk of the stock price declining post-split, which adds to the negative sentiment.

Positives

• The company is taking proactive steps to maintain its listing on The Nasdaq Capital Market, which could prevent adverse effects such as difficulty raising financing, reduced trading ability for investors, and loss of institutional investors.
• Any fractional shares resulting from the Reverse Stock Split will be rounded up to the nearest whole share, benefiting stockholders who would otherwise hold fractional interests.

Negatives

• The market price of the common stock may decline in value after the Reverse Stock Split due to variables outside the company's control, such as market volatility and investor response.
• A reverse stock split, while intended to address listing requirements, often signals underlying issues with a company's stock performance and can be viewed negatively by the market.

Risks

• Delisting from Nasdaq may adversely affect the company's ability to raise additional financing through public or private sales of equity securities.
• Delisting may significantly affect the ability of investors to trade in the company's securities and may negatively affect the value and liquidity of the common stock.
• Other negative impacts of delisting include potential loss of employee confidence, loss of institutional investors, loss of analyst coverage, or loss of business development opportunities.
• Despite the Board's belief that a reverse stock split will increase the trading price, the market price of the common stock may in fact decline in value after effecting the Reverse Stock Split due to variables outside of the company's control (e.g., market volatility, investor response, general economic environment).
• Should the overall value of the common stock decline after the proposed Reverse Stock Split, the actual or intrinsic value of shares held by stockholders will also proportionately decrease.

Future Outlook

The company anticipates that the Reverse Stock Split will increase the per share trading price of its common stock to maintain its Nasdaq listing. However, it cautions that the market price may still decline due to external factors, and the split does not affect the intrinsic value or proportional ownership, though overall value could decrease if the market price declines.

Management Comments

• Yi Lu, Chief Executive Officer, signed the Information Statement by order of the Board of Directors.
• The Board of Directors unanimously approved the corporate action on January 7, 2026.
• Management believes that a reverse stock split will increase the trading price of the common stock, but acknowledges that market price may decline due to variables outside of the company's control.

Industry Context

Reverse stock splits are a common strategy employed by companies whose stock price has fallen below minimum exchange listing requirements, such as Nasdaq's $1.00 bid price rule. This action aims to artificially inflate the per-share price to regain compliance, often indicating underlying challenges in the company's financial performance or market perception.

Corporate Governance

Stakeholder Impact

• Shareholders will own fewer shares of common stock after the Reverse Stock Split, though their percentage ownership will remain largely the same (except for fractional share rounding).
• The value and liquidity of common stock could be negatively affected if the market price declines post-split, despite the intention to increase it.
• Maintaining Nasdaq listing could benefit all stakeholders by preserving access to public markets and potentially facilitating future financing.

Next Steps

• The Board of Directors will determine the specific reverse stock split ratio within the approved range (1:2 to 1:100).
• The company will file a Certificate of Amendment to its Certificate of Incorporation with the Nevada Secretary of State to effectuate the Reverse Stock Split.
• The Reverse Stock Split is anticipated to become effective on February 13, 2026, or a later date specified in the filing.

Key Dates

Recommendation

A reverse stock split is typically a red flag, indicating the company's stock price has fallen significantly, often due to underlying operational or financial issues. While the stated goal of maintaining a Nasdaq listing is a necessary defensive move, it does not address the root causes of the low stock price. Investors should exercise extreme caution. A 'hold' recommendation implies waiting for further clarity on the company's fundamental performance and the market's reaction to the split, but it comes with significant risk. A seasoned investor would likely view this as a signal to re-evaluate their position, potentially considering a 'sell' if no clear path to improved fundamentals is evident.

Keywords

Reverse Stock Split, Nasdaq Listing, Stock Price, Corporate Governance, SEC Filing, Advanced Biomed Inc., Common Stock, Shareholder Approval